Immunoclin (Immunoclin) Total Stockholders Equity : $17.55 Mil (As of Oct. 2014)

View and export this data going back to 2012. Start your Free Trial

What is Immunoclin Total Stockholders Equity?

Immunoclin's Total Stockholders Equity for the quarter that ended in Oct. 2014 was $17.55 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Immunoclin's Book Value per Share for the quarter that ended in Oct. 2014 was $0.61. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Immunoclin's Debt-to-Equity for the quarter that ended in Oct. 2014 was 0.00.

Immunoclin Total Stockholders Equity Historical Data

The historical data trend for Immunoclin's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunoclin Total Stockholders Equity Chart

Immunoclin Annual Data

Trend

Feb12

Jan13

Jan14

Total Stockholders Equity

-0.08

-0.31

20.31

Immunoclin Quarterly Data
	May11	Aug11	Nov11	Feb12	May12	Aug12	Nov12	Feb13	May13	Aug13	Nov13	Apr14	Jul14	Oct14
Total Stockholders Equity	Get a 7-Day Free Trial									0.53	0.46	19.06	18.05	17.55

Immunoclin (GREY:IMCL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Immunoclin's Book Value per Share for the quarter that ended in Oct. 2014 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(17.55	-	0.001)	/	28.8312
	=	0.61

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Immunoclin's Debt-to-Equity for the quarter that ended in Oct. 2014 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	17.55
	=	0.00

Immunoclin Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Immunoclin's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Immunoclin (Immunoclin) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunoclin Corp (GREY:IMCL) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

9107 Wilshire Boulevard, Suite 450, Beverly Hills, CA, USA, 90210

Website

http://www.immunoclin.com

Immunoclin Corp is engaged in immunology research and development skill to serve the pharmaceutical, biotechnology and food industries, providing comprehensive, clinical and basic science research expertise at a commercial scale and quality.

Immunoclin (Immunoclin) Headlines

No Headlines